Promotion of Myelopoiesis in Myelosuppressed Mice by Ganoderma Lucidum Polysaccharides.

Xiao-Ling Zhu,Ji-Hong Liu,Wei-Dong Li,Zhi-Bin Lin
DOI: https://doi.org/10.3389/fphar.2012.00020
IF: 5.6
2012-01-01
Frontiers in Pharmacology
Abstract:Our previous studies demonstrated that Ganoderma lucidum polysaccharides (GI-PS) exhibit potent immunomodulating effects. Immunomodulation plays an important role in hematopoiesis. To investigate the possible mechanism by which GI-PS promote myelopoiesis during myelosuppression induced by cyclophosphamide, mice were injected intraperitoneally (i.p.) once daily with 2.5 mg/kg of GI-PS for 10 days and were treated i.p. once daily with cyclophosphamide (100 mg/kg) on days 2 through 4. In the present study in vivo and in vitro, we find that GI-PS selectively bind to bone marrow stromal cells, stimulate the secretion of hematopoietic growth factors, and enhance the clonogenic activities of hematopoietic and stromal cells to promote hematopoiesis in myelosuppressed mice.
What problem does this paper attempt to address?